Jiangsu Hualv Biological Technology Co.,Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 381.34 million compared to CNY 441.01 million a year ago. Revenue was CNY 381.34 million compared to CNY 441.01 million a year ago.

Net loss was CNY 4.11 million compared to net income of CNY 101.82 million a year ago. Basic loss per share from continuing operations was CNY 0.0352 compared to basic earnings per share from continuing operations of CNY 2.33 a year ago. Diluted loss per share from continuing operations was CNY 0.0352 compared to diluted earnings per share from continuing operations of CNY 2.33 a year ago.